127 related articles for article (PubMed ID: 3480370)
1. Nonrandom chromosomal changes in human solid tumors: application of an improved culture method.
Teyssier JR
J Natl Cancer Inst; 1987 Dec; 79(6):1189-98. PubMed ID: 3480370
[TBL] [Abstract][Full Text] [Related]
2. Identification of a clustering of chromosomal breakpoints in the analysis of 203 human primary solid tumor non specific karyotypic rearrangements.
Teyssier JR; Ferre D
Anticancer Res; 1992; 12(3):997-1004. PubMed ID: 1622159
[TBL] [Abstract][Full Text] [Related]
3. Application of cytogenetic methods to analysis of etiologic factors in carcinogenesis.
Mitelman F
IARC Sci Publ; 1982; (39):481-96. PubMed ID: 6759387
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
Mertens F; Johansson B; Höglund M; Mitelman F
Cancer Res; 1997 Jul; 57(13):2765-80. PubMed ID: 9205089
[TBL] [Abstract][Full Text] [Related]
5. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours.
Sjögren H; Orndal C; Tingby O; Meis-Kindblom JM; Kindblom LG; Stenman G
Int J Oncol; 2004 Jun; 24(6):1385-91. PubMed ID: 15138578
[TBL] [Abstract][Full Text] [Related]
7. SKY analysis of childhood neural tumors and cell lines demonstrates a susceptibility of aberrant chromosomes to further rearrangements.
Stanchescu R; Betts DR; Yekutieli D; Ambros P; Cohen N; Rechavi G; Amariglio N; Trakhtenbrot L
Cancer Lett; 2007 May; 250(1):47-52. PubMed ID: 17084022
[TBL] [Abstract][Full Text] [Related]
8. Borderline malignant serous tumors of the ovary maintained on extracellular matrix: evidence for clonal evolution and invasive potential.
Crickard K; Marinello MJ; Crickard U; Satchidanand SK; Yoonessi M; Caglar H
Cancer Genet Cytogenet; 1986 Oct; 23(2):135-43. PubMed ID: 3756833
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal changes associated with progression of the Dunning R-3327 rat prostatic adenocarcinoma system.
Wake N; Isaacs J; Sandberg AA
Cancer Res; 1982 Oct; 42(10):4131-42. PubMed ID: 7105009
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma.
Yoshida MA; Ohyashiki K; Ochi H; Gibas Z; Pontes JE; Prout GR; Huben R; Sandberg AA
Cancer Res; 1986 Apr; 46(4 Pt 2):2139-47. PubMed ID: 3948185
[TBL] [Abstract][Full Text] [Related]
11. Karyotypic evolution pathways in medulloblastoma/primitive neuroectodermal tumor determined with a combination of spectral karyotyping, G-banding, and fluorescence in situ hybridization.
Cohen N; Betts DR; Tavori U; Toren A; Ram T; Constantini S; Grotzer MA; Amariglio N; Rechavi G; Trakhtenbrot L
Cancer Genet Cytogenet; 2004 Feb; 149(1):44-52. PubMed ID: 15104282
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic analysis of 101 skull base tumors.
Gil Z; Orr-Urtreger A; Voskoboinik N; Trejo-Leider L; Shomrat R; Fliss DM
Head Neck; 2008 May; 30(5):567-81. PubMed ID: 18098307
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic analysis of human tumor cells cloned in agar.
Trent JM
Prog Clin Biol Res; 1980; 48():165-77. PubMed ID: 7193868
[TBL] [Abstract][Full Text] [Related]
14. [Significance of chromosomal abnormalities in solid tumors of humans].
Limon J; Mitelman F
Pol J Pathol; 1994; 45(1):1-15. PubMed ID: 8177615
[TBL] [Abstract][Full Text] [Related]
15. Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas.
Bayani J; Zielenska M; Pandita A; Al-Romaih K; Karaskova J; Harrison K; Bridge JA; Sorensen P; Thorner P; Squire JA
Genes Chromosomes Cancer; 2003 Jan; 36(1):7-16. PubMed ID: 12461745
[TBL] [Abstract][Full Text] [Related]
16. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
[TBL] [Abstract][Full Text] [Related]
17. Nonrandom chromosome changes in malignant melanoma.
Becher R; Gibas Z; Karakousis C; Sandberg AA
Cancer Res; 1983 Oct; 43(10):5010-6. PubMed ID: 6883347
[TBL] [Abstract][Full Text] [Related]
18. Chromosome abnormalities as primary events in human malignant disease: evidence from marker chromosomes.
Atkin NB; Baker MC
J Natl Cancer Inst; 1966 Mar; 36(3):539-57. PubMed ID: 18630328
[TBL] [Abstract][Full Text] [Related]
19. Assessment of methods for the cytogenetic analysis of human solid tumors.
Tanaka K; Testa JR
J Natl Cancer Inst; 1987 Dec; 79(6):1287-93. PubMed ID: 3480380
[TBL] [Abstract][Full Text] [Related]
20. Non-random primary and secondary chromosomal abnormalities in human gastric cancers.
Yadav M; Hopwood VL; Multani AS; Mansfield PF; Takahashi Y; McIntyre BW; Udagawa T; Pathak S
Anticancer Res; 1996; 16(4A):1787-95. PubMed ID: 8712702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
